Annals of Oncology

News:

US admits cancer victims among nuclear arms workers
Ann Oncol 11: 245.
[PDF] [Request Permissions]

NHS remains in the limelight
Ann Oncol 11: 245-246.
[PDF] [Request Permissions]

‘Globalizers’ most worried about global warming
Ann Oncol 11: 246.
[PDF] [Request Permissions]

After 50 years, the Dutch Cancer Society enters a new era
Ann Oncol 11: 246-247.
[PDF] [Request Permissions]

R. Antonini

Health Care: A top issue for US Democrats in the election year
Ann Oncol 11: 247-248.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 11: 248-251.
[PDF] [Request Permissions]

Book reviews:

C. Sessa

Book review
Ann Oncol 11: 251.
[PDF] [Request Permissions]

O. De Cobelli

Book review
Ann Oncol 11: 252.
[PDF] [Request Permissions]

R. Gennari

Book review
Ann Oncol 11: 376.
[PDF] [Request Permissions]

Editorials:

D. Kerr

World summit against cancer for the new millennium: The Charter of Paris
Ann Oncol 11: 253-254.
[PDF] [Request Permissions]

E. S. R. Collie-Duguid, H. L. McLeod, and J. Cassidy

Estimation of dihydropyrimidine dehydrogenase activity: Does it have a role in cancer therapy?
Ann Oncol 11: 255-257.
[PDF] [Request Permissions]

R. Silvestrini

Relevance of DNA-ploidy as a prognostic instrument for solid tumors
Ann Oncol 11: 259-261.
[PDF] [Request Permissions]

Review:

U. Göbel, D. T. Schneider, G. Calaminus, R. J. Haas, P. Schmidt, and D. Harms GPOH MAKEI and the MAHO study groups

Germ-cell tumors in childhood and adolescence
Ann Oncol 11: 263-271.
[Abstract] [PDF] [Request Permissions]

Original articles:

T. Takenoue, J. Kitayama, Y. Takei, N. Umetani, K. Matsuda, M. E. Nita, K. Hatano, T. Tsuruo, and H. Nagawa

Characterization of dihydropyrimidine dehydrogenase on immunohisto-chemistry in colon carcinoma, and correlation between immunohisto-chemical score and protein level or messenger RNA expression
Ann Oncol 11: 273-279.
[Abstract] [PDF] [Request Permissions]

C. Tropé, J. Kaern, T. Hogberg, V. Abeler, B. Hagen, G. Kristensen, M. Onsrud, E. Pettersen, P. Rosenberg, R. Sandvei, K. Sundfor, and I. Vergote

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Ann Oncol 11: 281-288.
[Abstract] [PDF] [Request Permissions]

M. Tomamichel, H. Jaime, A. Degrate, J. de Jong, O. Pagani, F. Cavalli, and C. Sessa

Proposing phase I studies: Patients', relatives', nurses' and specialists' perceptions
Ann Oncol 11: 289-294.
[Abstract] [PDF] [Request Permissions]

H. Imam, B. Eriksson, and K. Öberg

Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours
Ann Oncol 11: 295-300.
[Abstract] [PDF] [Request Permissions]

A. D. Roth, R. Maibach, G. Martinelli, N. Fazio, M. S. Aapro, O. Pagani, R. Morant, M. M. Borner, R. Herrmann, H. Honegger, F. Cavalli, P. Alberto, M. Castiglione, and A. Goldhirsch Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland and the European Institute of Oncology (EIO), Milan, Italy

Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma
Ann Oncol 11: 301-306.
[Abstract] [PDF] [Request Permissions]

W. D. Foulkes, P. O. Chappuis, N. Wong, J.-S. Brunet, D. Vesprini, F. Rozen, Z. Q. Yuan, M. N. Pollak, G. Kuperstein, S. A. Narod, and L. R. B{acute}gin

Primary node negative breast cancer in BRCAI mutation carriers has a poor outcome
Ann Oncol 11: 307-313.
[Abstract] [PDF] [Request Permissions]

S. Z. Gertler, D. MacDonald, M. Goodyear, P. Forsyth, D. J. Stewart, K. Belanger, J. Perry, D. Fulton, W. Steward, N. Wainman, and L. Seymour

NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94)
Ann Oncol 11: 315-318.
[Abstract] [PDF] [Request Permissions]

A. Casamassimi, A. De Luca, S. Agrawal, K. Stromberg, D. S. Salomon, and N. Normanno

EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells
Ann Oncol 11: 319-325.
[Abstract] [PDF] [Request Permissions]

M. Salden, T. A. W. Splinter, H. A. Peters, M. P. Look, M. Timmermans, J. P. A. M. van Meerbeeck, and J. A. Foekens on behalf of the Rotterdam Oncology Thoracic Study Group

The urokinase-type plasminogen activator system in resected non-small-cell lung cancer
Ann Oncol 11: 327-332.
[Abstract] [PDF] [Request Permissions]

A. W. Tolcher, C. Aylesworth, J. Rizzo, E. Izbicka, E. Campbell, J. Kuhn, G. Weiss, D. D. Von Hoff, and E. K. Rowinsky

A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors
Ann Oncol 11: 333-338.
[Abstract] [PDF] [Request Permissions]

F. Caponigro, P. Cornelia, A. Budillon, J. Bryce, A. Avallone, V. De Rosa, F. Ionna, and G. Cornelia

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
Ann Oncol 11: 339-342.
[Abstract] [PDF] [Request Permissions]

I. Popov, S. Jelic, S. Radulovic, D. Radosavljevic, and Z. Nikolic-Tomasevic

Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial
Ann Oncol 11: 343-348.
[Abstract] [PDF] [Request Permissions]

Clinical case:

R.-L. Hong, Y.-L. Tseng, and F.-H. Chang

Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
Ann Oncol 11: 349-353.
[Abstract] [PDF] [Request Permissions]

J. Dumortier, G. Freyer, A. J. Sasco, L. Frappart, T. Zénone, P. Romestaing, and V. Trillet-Lenoir

Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: Report on a new case and review of the literature
Ann Oncol 11: 355-358.
[Abstract] [PDF] [Request Permissions]

Short report:

J. O. Armitage and B. Coiffier

Activity of interferon- in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma
Ann Oncol 11: 359-361.
[PDF] [Request Permissions]

P. L. Zinzani, M. Magagnoli, M. Bendandi, F. Gherlinzoni, G. Fraternali Orcioni, C. Cellini, V. Stefoni, S. A. Pileri, and S. Tura

Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
Ann Oncol 11: 363-365.
[Abstract] [PDF] [Request Permissions]

G. Frasci, P. Cornella, G. D'Aiuto, R. Thomas, I. Capasso, M. Elmo, G. Botti, G. R. Cortino, L. Lapenta, V. De Rosa, P. Vallone, A. Petrillo, G. Cornella, and Southern Italy Cooperative Oncology Group (SICOG)

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study
Ann Oncol 11: 367-371.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

G. Toffoli, A. Veronesi, M. Boiocchi, and D. Crivellari

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)
Ann Oncol 11: 373-374.
[PDF] [Request Permissions]

T. W. Ruhstaller, U. Amsler, and T. Cerny

Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
Ann Oncol 11: 374-375.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.